Absorbed doses in the tumour were high for both EGFR-targeted (30.4 Gy) and non-targeted AuNPs (21.9 Gy) but normal organ doses were very low (0.04–0.6 Gy) (Fig. 5d). This evidence concerns the gene EGFR and neoplasm.